Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses | Science
PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity
Emerging biomarkers as predictors to anti-PD1/PD-L1 therapies in advanced melanoma | Immunotherapy
Role of PD-1 during effector CD8 T cell differentiation | PNAS
Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy | Molecular Cancer | Full Text
Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapy - ScienceDirect
Raji-hPD-1 cells | ADCC targets | InvivoGen
Frontiers | PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
Release the B7.1! Anti-PD-L1 breaks PD-L1's grip
Early serum tumor marker dynamics predict progression-free and overall survival in single PD-1/PD-L1 inhibitor treated advanced NSCLC—A retrospective cohort study - Lung Cancer
IVD Antibody Development Services for PD-L1 Marker - Creative Biolabs
Anti-PDL-1 Antibody Treatment Reduces Expression of the Exhaustion Marker PD -1 in T Cells | Biocompare Antibody Review
Learning from PD-1 Resistance: New Combination Strategies: Trends in Molecular Medicine
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors | Molecular Cancer | Full Text
Cancer immunotherapy and the PD-1/PD-L1 checkpoint pathway | Abcam
Predictive Markers for the Efficacy of Anti–PD-1/PD-L1 Antibodies in Lung Cancer - ScienceDirect
IRF-1 as a predictive marker for anti-PD-1 therapy. a IRF-1 expression... | Download Scientific Diagram
PD-L1+CD8+ T cells enrichment in lung cancer exerted regulatory function and tumor-promoting tolerance - ScienceDirect
PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer | PNAS
Frontiers | Tumor-Infiltrating PD-1hiCD8+-T-Cell Signature as an Effective Biomarker for Immune Checkpoint Inhibitor Therapy Response Across Multiple Cancers
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity | Nature
Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation - Pathology
